Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunction5'-nucleotidase activity

NT5C NT5M

3.84e-0415392GO:0008253
GeneOntologyMolecularFunctiondiacylglycerol-dependent serine/threonine kinase activity

PRKD3 PRKD2

4.38e-0416392GO:0004697
GeneOntologyMolecularFunctionnucleotidase activity

NT5C NT5M

5.58e-0418392GO:0008252
GeneOntologyBiologicalProcessdUMP catabolic process

NT5C NT5M

6.90e-057382GO:0046079
GeneOntologyBiologicalProcessdUMP metabolic process

NT5C NT5M

9.19e-058382GO:0046078
GeneOntologyBiologicalProcesspyrimidine nucleoside monophosphate catabolic process

NT5C NT5M

1.47e-0410382GO:0009131
GeneOntologyBiologicalProcesspyrimidine deoxyribonucleoside monophosphate catabolic process

NT5C NT5M

1.47e-0410382GO:0009178
Domain5'(3')-deoxyribonucleotidase

NT5C NT5M

4.47e-062402IPR010708
DomainNT5C

NT5C NT5M

4.47e-062402PF06941
DomainProtein_Kinase_C_mu-related

PRKD3 PRKD2

1.34e-053402IPR015727
DomainDAG/PE-bd

PRKD3 PRKD2

9.15e-0421402IPR020454
DomainPH

PRKD3 PRKD2 DOK2 RTKN

1.42e-03229404PF00169
DomainAAA

ATAD3C NSF

2.40e-0334402PS00674
DomainPH

PRKD3 PRKD2 DOK2 RTKN

2.88e-03278404SM00233
DomainPH_DOMAIN

PRKD3 PRKD2 DOK2 RTKN

2.92e-03279404PS50003
DomainPH_domain

PRKD3 PRKD2 DOK2 RTKN

2.96e-03280404IPR001849
DomainAAA

ATAD3C NSF

5.54e-0352402PF00004
DomainBTB_2

KCTD12 KCTD16

5.75e-0353402PF02214
DomainT1-type_BTB

KCTD12 KCTD16

5.75e-0353402IPR003131
DomainGlycoside_hydrolase_SF

HPSE2 GAA

5.75e-0353402IPR017853
DomainATPase_AAA_core

ATAD3C NSF

5.97e-0354402IPR003959
DomainC1_1

PRKD3 PRKD2

6.63e-0357402PF00130
DomainZF_DAG_PE_1

PRKD3 PRKD2

8.29e-0364402PS00479
DomainZF_DAG_PE_2

PRKD3 PRKD2

8.29e-0364402PS50081
Domain-

NT5C NT5M

8.29e-03644023.40.50.1000
DomainC1

PRKD3 PRKD2

8.54e-0365402SM00109
DomainPE/DAG-bd

PRKD3 PRKD2

8.80e-0366402IPR002219
Domain-

PRKD3 PRKD2 DOK2 RTKN

9.54e-033914042.30.29.30
DomainHAD-like_dom

NT5C NT5M

1.24e-0279402IPR023214
DomainPH_dom-like

PRKD3 PRKD2 DOK2 RTKN

1.28e-02426404IPR011993
PathwayREACTOME_PYRIMIDINE_CATABOLISM

NT5C NT5M

2.54e-0411312MM15423
PathwayKEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_HYPOXANTHINE_GUANINE_TO_IMP_GMP

NT5C NT5M

2.54e-0411312M47820
PathwayKEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_ADENINE_TO_AMP

NT5C NT5M

2.54e-0411312M47819
PathwayREACTOME_PYRIMIDINE_CATABOLISM

NT5C NT5M

3.05e-0412312M10654
PathwayKEGG_MEDICUS_ENV_FACTOR_METALS_TO_NFKB_SIGNALING_PATHWAY

PRKD3 PRKD2

4.83e-0415312M47816
Pubmed

Protein kinase D regulates RhoA activity via rhotekin phosphorylation.

PRKD3 PRKD2 RTKN

1.41e-08540322228765
Pubmed

Opposing growth regulatory roles of protein kinase D isoforms in human keratinocytes.

PRKD3 PRKD2

1.29e-06240225802335
Pubmed

Protein kinase d isoforms differentially modulate cofilin-driven directed cell migration.

PRKD3 PRKD2

1.29e-06240224840177
Pubmed

A deoxyribonucleotidase in mitochondria: involvement in regulation of dNTP pools and possible link to genetic disease.

NT5C NT5M

1.29e-06240210899995
Pubmed

Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment.

PRKD3 PRKD2

1.29e-06240230841931
Pubmed

Protein kinases D2 and D3 are novel growth regulators in HCC1806 triple-negative breast cancer cells.

PRKD3 PRKD2

1.29e-06240223393329
Pubmed

KCTD Hetero-oligomers Confer Unique Kinetic Properties on Hippocampal GABAB Receptor-Induced K+ Currents.

KCTD12 KCTD16

1.29e-06240228003345
Pubmed

Protein kinase D3 conditional knockout impairs osteoclast formation and increases trabecular bone volume in male mice.

PRKD3 PRKD2

1.29e-06240237044359
Pubmed

Mouse cytosolic and mitochondrial deoxyribonucleotidases: cDNA cloning of the mitochondrial enzyme, gene structures, chromosomal mapping and comparison with the human orthologs.

NT5C NT5M

1.29e-06240212234672
Pubmed

Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse model.

PRKDC GAA

1.29e-06240215356673
Pubmed

KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons.

KCTD12 KCTD16

3.87e-06340235017224
Pubmed

Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer.

PRKD3 PRKD2

3.87e-06340226253275
Pubmed

Expression of the protein kinase D (PKD) family during mouse embryogenesis.

PRKD3 PRKD2

3.87e-06340216377259
Pubmed

A Novel Conserved Domain Mediates Dimerization of Protein Kinase D (PKD) Isoforms: DIMERIZATION IS ESSENTIAL FOR PKD-DEPENDENT REGULATION OF SECRETION AND INNATE IMMUNITY.

PRKD3 PRKD2

3.87e-06340227662904
Pubmed

Inhibition of protein kinase D by CID755673 promotes maintenance of the pluripotency of embryonic stem cells.

PRKD3 PRKD2

3.87e-06340232747433
Pubmed

Lack of PRKD2 and PRKD3 kinase domain somatic mutations in PRKD1 wild-type classic polymorphous low-grade adenocarcinomas of the salivary gland.

PRKD3 PRKD2

3.87e-06340226426580
Pubmed

Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain.

KCTD12 KCTD16

3.87e-06340221452234
Pubmed

Effect of deletion of the protein kinase PRKD1 on development of the mouse embryonic heart.

PRKD3 PRKD2

3.87e-06340238419169
Pubmed

Protein kinase D regulates positive selection of CD4+ thymocytes through phosphorylation of SHP-1.

PRKD3 PRKD2

7.73e-06440227670070
Pubmed

Native GABA(B) receptors are heteromultimers with a family of auxiliary subunits.

KCTD12 KCTD16

7.73e-06440220400944
Pubmed

Protein kinase D regulates basolateral membrane protein exit from trans-Golgi network.

PRKD3 PRKD2

7.73e-06440214743217
Pubmed

Plk4 is required for cytokinesis and maintenance of chromosomal stability.

PRKDC RTKN

1.93e-05640220348415
Pubmed

DNA-dependent protein kinase (DNA-PK) phosphorylates nuclear DNA helicase II/RNA helicase A and hnRNP proteins in an RNA-dependent manner.

PRKDC HNRNPAB

1.93e-05640214704337
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

HNRNPDL KCTD12 PRKD2 PRKDC DDX55 NSF HNRNPAB KCTD16 FTSJ3

2.75e-05142540930948266
Pubmed

Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer.

HNRNPDL PRKDC HNRNPAB

3.00e-055240324591637
Pubmed

Dissecting the Roles of Mitochondrial Complex I Intermediate Assembly Complex Factors in the Biogenesis of Complex I.

TMEM186 NDUFAF1

4.62e-05940232320651
Pubmed

RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.

HNRNPDL PRKDC DDX55 HNRNPAB FTSJ3

1.23e-0442540521081503
Pubmed

ATG5 is required for B cell polarization and presentation of particulate antigens.

HNRNPDL PRKD2 ATAD3C DDX55 HNRNPAB FTSJ3

1.41e-0470140630196744
Pubmed

Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.

HNRNPDL PRKDC DDX55 HNRNPAB FTSJ3

2.29e-0448640530940648
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

KCTD12 PRKD2 ZER1 CACNA1H MGAT4B PRKDC EIF4ENIF1

2.39e-04110540735748872
Pubmed

A digenic cause of cleft lip in A-strain mice and definition of candidate genes for the two loci.

MTRR NSF

2.42e-042040215329828
Pubmed

Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.

HNRNPDL DDX55 HNRNPAB FTSJ3

2.64e-0427140432433965
Pubmed

Mammalian splicing factor SF1 interacts with SURP domains of U2 snRNP-associated proteins.

HNRNPDL HNRNPAB

2.94e-042240226420826
Pubmed

Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response.

MGAT4B GAA

2.94e-04224028673525
Pubmed

Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation.

MGAT4B GAA

2.94e-04224029109416
Pubmed

Folding of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum.

MGAT4B GAA

2.94e-042240211530211
Pubmed

Confirmational, provisional, and/or regional assignment of 15 enzyme loci onto Chinese hamster autosomes 1, 2, and 7.

GAA ACP2

2.94e-04224027323947
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

HNRNPDL KCTD12 PRKDC EIF4ENIF1 HNRNPAB FTSJ3

3.00e-0480740622681889
Pubmed

Role of asparagine-linked glycosylation in human immunodeficiency virus type 1 transmembrane envelope function.

MGAT4B GAA

3.21e-04234021736542
Pubmed

Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.

MGAT4B GAA

3.21e-04234028093218
Pubmed

Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins.

MGAT4B GAA

3.21e-04234023099781
Pubmed

Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1.

MGAT4B GAA

3.21e-04234023264072
Pubmed

Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer-related pathways in breast cancer.

PRKD3 PRKD2 SLC4A3

3.26e-0411640330652415
Pubmed

Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication.

HNRNPDL HNRNPAB FTSJ3

3.69e-0412140334029587
Pubmed

Chromosomal assignments of 23 biochemical loci of the rat by using rat x mouse somatic cell hybrids.

NT5C ACP2

5.50e-04304021914521
Pubmed

Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.

HNRNPDL PRKDC

5.50e-043040221575865
Pubmed

Large-scale mapping of human protein-protein interactions by mass spectrometry.

HNRNPDL KCTD12 DOK2 NDUFAF1 NSF HNRNPAB FTSJ3

5.89e-04128440717353931
Pubmed

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

HNRNPDL PRKDC DDX55 HNRNPAB FTSJ3

6.23e-0460540528977666
Pubmed

Interaction proteomics of the HMGA chromatin architectural factors.

HNRNPDL HNRNPAB

6.26e-043240218850631
Pubmed

Transgenic mouse proteomics identifies new 14-3-3-associated proteins involved in cytoskeletal rearrangements and cell signaling.

ATAD3C NSF KCTD16

6.52e-0414740316959763
Pubmed

Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport.

MGAT4B GAA

8.37e-04374022542563
Pubmed

Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.

MGAT4B GAA

8.37e-04374022541446
Pubmed

Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV-1) pathogenesis.

MGAT4B GAA

8.83e-04384022829950
Pubmed

Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.

MGAT4B GAA

8.83e-04384022187500
Pubmed

Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics.

HNRNPDL PRKDC HNRNPAB FTSJ3

9.77e-0438440431059266
InteractionGABBR2 interactions

KCTD12 NSF KCTD16

1.69e-0526393int:GABBR2
InteractionEIF4EBP1 interactions

DDIT4L PRKDC EIF4ENIF1 HNRNPAB

3.22e-0594394int:EIF4EBP1
GeneFamilyCD molecules|5'-nucleotidases

NT5C NT5M

3.53e-0572421042
GeneFamilyAAA ATPases

ATAD3C NSF

2.23e-0353242413
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

PRKD3 PRKD2 RTKN

2.47e-03206243682
ToppCellBronchus_Control_(B.)-Endothelial-TX-Endothelial-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type

DDIT4L CYSLTR1 NT5C SLC27A5

8.48e-0781404a1193b2cfb84a6b6593779fef5f54a61567a12d7
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CYP2S1 LDLRAD2 SLC4A3 KCNK15

1.10e-051544045967a0a33456d5930fc492a700ebb015ac050abb
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CYP2S1 LDLRAD2 SLC4A3 KCNK15

1.12e-05155404fab281db4c275d51240b122be78713c839ba5a95
ToppCellsevere-Myeloid-mDC|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

KCTD12 CYP2S1 LDLRAD2 SLC4A3

1.51e-0516740450b1cea9048bd8df9aff3fb9a548443f950d1090
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KCTD12 NUP210L SIGLEC8 GAA

1.77e-05174404d5c22b43531414951666ee7542a66ed9380e2d14
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CYP2S1 LDLRAD2 SLC4A3 KCTD16

1.89e-05177404e68ad19963a3d8917dfdb81127a41c4fcbe61dd5
ToppCell10x5'v1-week_12-13-Myeloid_DC-DC|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

KCTD12 CYP2S1 LDLRAD2 SLC4A3

2.40e-051884046b0e0192519ea3ca49fb21de3da9a0a108fcb64d
ToppCell10x5'v1-week_12-13-Myeloid_DC|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

KCTD12 CYP2S1 LDLRAD2 SLC4A3

2.40e-051884040b19c35fdc2b9e064e8f03ef69ae08644794ec24
ToppCellNS-critical-LOC-Myeloid-Macrophage|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ANKRD29 KCTD12 GAA ACP2

2.88e-051974045fb0696376a5501b7c87e0f2f5e4fff3da2903f2
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ZER1 DOK2 CYP2S1 GAA

3.05e-0520040488d713dfc792e7609bf7ecfb28f87cb748088570
ToppCellE16.5-samps-Mesenchymal-Myofibroblast-Smooth_Muscle-like_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass

DDIT4L HPSE2 KCTD16

2.68e-041404035623a0a68403fc00166b7d13d13e184a718d9bdd
ToppCellfacs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PRKDC AGBL5 NUP210L

2.85e-04143403b4ed3855652fdf32f97cb7c18cab4f4f4c24d5c7
ToppCellBAL-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CYP2S1 SLC4A3 SIGLEC8

3.34e-041514030b6b37734430918378ed94e40877f0c4ae9b25ec
ToppCellfacs-Aorta-Heart-3m-Epithelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDIT4L SLC4A3 SLC27A5

3.34e-04151403bee48137d1f5f27a24571a59c835284651d38538
ToppCellfacs-Aorta-Heart-3m-Epithelial-epithelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDIT4L SLC4A3 SLC27A5

3.34e-041514030de76acd1b204345dce7f33be2a1ed9fbe9e6da0
ToppCellBAL-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CYP2S1 SLC4A3 SIGLEC8

3.34e-0415140330225a1a7800b0ae19e16ac164f561379eedb99d
ToppCellfacs-Aorta-Heart-3m-Epithelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDIT4L SLC4A3 SLC27A5

3.34e-0415140320b9c8fb966c5d62ff909cc4a4616b109b78cdca
ToppCellnormal_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass

KCTD12 SIGLEC8 ACP2

3.47e-041534035424494ea1f09542799045a875cc3eac13de5079
ToppCellMonocytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id

DDIT4L KCTD12 NUP210L

3.61e-0415540382abfcee23ba08a1eb4208d367393285026e5388
ToppCell10x5'v1-week_12-13-Myeloid_DC-DC-DC2|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

KCTD12 CYP2S1 SLC4A3

3.68e-0415640303f3c5ffb27758fe63797143fcc938f9e8a4e10d
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

KCTD12 CYP2S1 SLC4A3

3.75e-04157403e9d0300361b06aec3c216f8af15f09e14b12a4da
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

KCTD12 CYP2S1 SLC4A3

3.82e-04158403e9657d8960d499832f9f9b45b5a6f4388551b7e1
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-microglial_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

RLBP1 KCTD12 SIGLEC8

3.89e-0415940331ec8222c766cb614e1cf27f74ee9d99489eca5c
ToppCellControl-Mast_cells-Transitioning_MDM|Control / group, cell type (main and fine annotations)

CACNA1H NDUFAF1 NT5M

4.03e-041614035807ee48f871a3eb24ebf78fd107cf5f2a4ec846
ToppCellsevere_influenza-cDC|World / disease group, cell group and cell class (v2)

CYP2S1 SLC4A3 KCTD16

4.03e-04161403802f8cafb5f499e3b2ec0193d6eb1ac9320b9287
ToppCellTCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-1|TCGA-Mesothelium / Sample_Type by Project: Shred V9

TMEM186 SLC4A3 KCNK15

4.03e-041614039e03aa7c50b4e8cf1f726a524b5b03af886535b1
ToppCellsevere_influenza-cDC|severe_influenza / disease group, cell group and cell class (v2)

CYP2S1 SLC4A3 KCTD16

4.03e-041614037716315b8bda904b346cea47edc2c0b507a345c2
ToppCellE18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

KCTD12 DOK2 CYSLTR1

4.11e-04162403ec29c6f1c31e41ddcb041a49c593910edaf0532c
ToppCellInfluenza_Severe-cDC|World / Disease group and Cell class

CYP2S1 SLC4A3 KCTD16

4.25e-04164403c984228f73b9aa1aaf948541f64f41ed874770cd
ToppCellfacs-Diaphragm-Limb_Muscle-3m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

4.33e-04165403518ee34c18065100a2f2c6e407d3a7866b908593
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

KCTD12 SLC4A3 HNRNPAB

4.33e-0416540360b500eb2c10cccf309b8fb28a9119da22d6889c
ToppCellfacs-Diaphragm-Limb_Muscle-3m-Myeloid-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

4.33e-04165403becb8f726b84509ec29c75b530a3fe757651301d
ToppCellfacs-Diaphragm-Limb_Muscle-3m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

4.33e-04165403ae8dd9c00f96590f27ed21cd6314f4577e00e312
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

LDLRAD2 SLC4A3 KCNK15

4.41e-04166403b1bebcbe17386cb102b11d551e62d46156ce0c68
ToppCellInfluenza_Severe-cDC|Influenza_Severe / Disease group and Cell class

CYP2S1 SLC4A3 KCTD16

4.41e-04166403b40bdf0f7f381e25be61188e9f6c294d25a8b824
ToppCellmild_COVID-19_(asymptomatic)-Plasmablast|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)

ATAD3C NUP210L FTSJ3

4.41e-041664030cc3b9681bc000a1b00d3b60f79f16eea1c2e2e1
ToppCellfacs-SCAT-Fat-3m-Myeloid-myeloid_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

4.41e-041664038395c74db8e4e54af97a3f2b75cb75171140ec31
ToppCellfacs-SCAT-Fat-3m-Myeloid|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

4.41e-0416640376807edc5620514b53a14be354b84c54c112b8f9
ToppCellfacs-SCAT-Fat-3m-Myeloid-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

4.41e-04166403645b842b94b8d2f4b26c2623f8589f56bd782c26
ToppCellfacs-MAT-Fat-18m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

4.49e-04167403c2952d8ba763374c5678b92825c8956fc3e3ecd2
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

LDLRAD2 SLC4A3 KCNK15

4.49e-04167403e44743b20a7435c579d8e999ddc4ca119d6753f2
ToppCellfacs-Heart-RV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

4.56e-04168403a405f0de70293f68b4e000c1fc8a9ad33d56539a
ToppCellfacs-Heart-RV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

4.56e-041684038ee57814c7e9d45444f48b6b269c4d535bc4d5e1
ToppCellsevere-Myeloid-mDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

CYP2S1 LDLRAD2 SLC4A3

4.56e-04168403eff37a92d41624924201372cc09f9eb07b60aec1
ToppCellfacs-Heart-RV-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

4.56e-04168403c1a5f4f4d32a1f8583048db709a7037cc9357ad8
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

KCTD12 GAA ACP2

4.64e-04169403e3100eb587005e160bd0b7990fa57ec49765133d
ToppCellfacs-GAT-Fat-3m-Myeloid-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

4.81e-041714033f796d53d3110e5d6e97de53bb49d323944659d6
ToppCellfacs-GAT-Fat-3m-Myeloid-myeloid_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

4.81e-04171403d9fbc2b00dbf9dddc95d9a20d804459a9ebd1820
ToppCellfacs-GAT-Fat-3m-Myeloid|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

4.81e-04171403e77bfc925d73ccffe3c8cfb13764e70579a7f942
ToppCellPND07-28-samps-Myeloid-Macrophage-CD163+_Macrophage|PND07-28-samps / Age Group, Lineage, Cell class and subclass

KCTD12 DOK2 CYSLTR1

4.89e-041724039a659442dc41bd2a4361a7e38a7ee37a39781667
ToppCellfacs-Heart-RA-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

4.97e-041734035058cb5e3f2d57dbe947e1b113eb2bef7bf6dd7d
ToppCellfacs-Heart-RA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

4.97e-041734034fa5f502fa3ff8f888e279f68a0dafd91b37f26f
ToppCellfacs-Heart-RA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

4.97e-04173403ea406b47ff3ead992bc06f6b1707c76eee574782
ToppCellfacs-Heart-LA-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

5.06e-0417440330c083fe4711735e83dccfd00fcd746ae673d353
ToppCellfacs-Heart-LA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

5.06e-0417440346d19c1144fff19be682b7ba59d4c3e014f79e15
ToppCellfacs-Heart-LA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 CYSLTR1

5.06e-041744031802a52552256d1e25d8b328ba62dcfe41671900
ToppCellCOVID-mDC1-|COVID / Condition, Cell_class and T cell subcluster

CYP2S1 LDLRAD2 SLC4A3

5.14e-0417540383a95d6fc2ddf3ec53f05825bbc982fb8d2ccd15
ToppCell3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRKD3 TSPEAR ATAD3C

5.14e-0417540343be63976da5ad0764d24d90919a77ce46068f52
ToppCellCOVID-mDC1|COVID / Condition, Cell_class and T cell subcluster

CYP2S1 LDLRAD2 SLC4A3

5.14e-04175403b9280444016e21c28131a61df65cc5c56d402412
ToppCell10x5'v1-week_14-16-Myeloid_DC-DC-tDC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KCTD12 CYP2S1 SLC4A3

5.23e-04176403fb07a047a3a7a8d03bfcc28eea3da2eaa0f6b733
ToppCellAdult-Immune-enucleated_erythrocyte-D231|Adult / Lineage, Cell type, age group and donor

CYP2S1 NUP210L SLC27A5

5.31e-0417740315ee303fb6caea1fd645c3b777666196ce500a1c
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDIT4L PRKD3 DOK2

5.40e-041784030f5cf34609df791c8baebfdc6590f6eb4dbe0509
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDIT4L PRKD3 DOK2

5.40e-04178403d9eba884e18a0c89bdc70c194bfe4d62cca164fa
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDIT4L PRKD3 DOK2

5.40e-04178403b03aa1de9d20895ebad55f6fcd6fe7a49335db5a
ToppCell343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

LDLRAD2 KCNK15 NT5M

5.40e-04178403c7e890cd02206c516cf1d7692ea7abc8ce746482
ToppCellnormal_Lymph_Node-Myeloid_cells-CD141+_DCs|normal_Lymph_Node / Location, Cell class and cell subclass

KCTD12 CYP2S1 KCNK15

5.49e-04179403ec995ccd6e1dbd06287ad836c232d9aed1cf94a8
ToppCellILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

TSPEAR ANKRD29 KCTD12

5.49e-0417940399777a8931356d1206b8ab22aaa1b1d5a600b809
ToppCellControl-Myeloid-DC1|Control / Condition, Lineage and Cell class

CYP2S1 LDLRAD2 SLC4A3

5.67e-041814035a2a1f017ad23baed9972c68b4a46f4c618ef21a
ToppCellCOVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class

PRKD3 CACNA1H NT5M

5.67e-041814034a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4
ToppCell343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

LDLRAD2 KCNK15 NT5M

5.76e-04182403b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1
ToppCell3'_v3-GI_small-bowel-Myeloid_Dendritic-DC2|GI_small-bowel / Manually curated celltypes from each tissue

KCTD12 CYP2S1 SLC4A3

5.85e-04183403c94ee9f35b21252e1ab5ab15b6a2ce69a7d753f7
ToppCell10x5'v1-week_17-19-Myeloid_DC-DC-DC3|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

KCTD12 DOK2 CYP2S1

5.85e-04183403c6cac433ea7a3d60728efdc7051e09e01bb3ade5
ToppCelldroplet-Liver-LIVER-NPC-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCTD12 DOK2 ACP2

5.85e-04183403c12a4603cf81b5736553a4530cea5cefab80556f
ToppCellmild-Myeloid-mDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

KCTD12 CYP2S1 SLC4A3

5.95e-041844038b37c00d59d9992d3b43268991da7bb94646c70e
ToppCellControl-Myeloid-DC1|Myeloid / Condition, Lineage and Cell class

CYP2S1 LDLRAD2 SLC4A3

5.95e-04184403b5c1f57f0356969cfb0e1dac764684fc5583bc04
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DDIT4L CYP2S1 GAA

6.04e-041854036da9a06e1514d5d5f47359a14637f02539846096
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DDIT4L CYP2S1 GAA

6.04e-041854034a188e2566a75d1b4f3c879a8c241c277c4b451c
ToppCellCOVID_non-vent-Myeloid-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

KCTD12 SLC4A3 HNRNPAB

6.23e-04187403936aaca144b79a809617cbe3058bf434a4b3d46a
ToppCellCOVID_non-vent-Myeloid-Dendritic-cDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

KCTD12 SLC4A3 HNRNPAB

6.23e-0418740355fe4e8b4f301876716c1af15c34d42164f2358e
ToppCellControl-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class

ANKRD29 LDLRAD2 CYSLTR1

6.23e-041874035429ae85942b8ec3895cceb63c663de3c24ca064
ToppCell10x3'2.3-week_14-16-Myeloid_DC-DC-DC2|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KCTD12 CYP2S1 SLC4A3

6.33e-0418840315d8dc514d5da46f6af284e7c1c92c606712dae6
ToppCellnormal_Lymph_Node-Myeloid_cells-mo-Mac|normal_Lymph_Node / Location, Cell class and cell subclass

KCTD12 SIGLEC8 ACP2

6.33e-04188403e83de94a9b47a6a90e98face887eae031a322af6
ToppCellkidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ANKRD29 KCTD12 LDLRAD2

6.33e-04188403a37edd8f9e4a4e336b5acbb0407d3d275975cee8
ToppCell3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KCTD12 SIGLEC8 ACP2

6.33e-04188403fcf1bebef7aa81b4a11c1f9e4319339c290ecd22
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

KCTD12 SLC4A3 ACP2

6.43e-041894030a490730cdc912d5233de59057550de0e4065747
ToppCell10x5'v1-week_14-16-Myeloid_DC-DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KCTD12 CYP2S1 SLC4A3

6.53e-04190403d06800ec9f6065c1cc536ed99e8569732272a94f
ToppCell10x5'v1-week_14-16-Myeloid_DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KCTD12 CYP2S1 SLC4A3

6.53e-04190403485073e831afebdb393c7f4b622504d43d1b778b
ToppCellCOVID-19-Myeloid-DC2|COVID-19 / Condition, Lineage and Cell class

CYP2S1 LDLRAD2 SLC4A3

6.63e-041914031304ab7b5713f29f3966ffc020ea1b52e8e2f375
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KCTD12 CYP2S1 SLC4A3

6.73e-04192403e24a8856ef01ccf69a5e968bd409f9b84befa91e
ToppCell10x3'2.3-week_14-16-Myeloid_DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KCTD12 SLC4A3 CYSLTR1

6.83e-04193403c6633aca0eb4d699c4d3da3199b84bebd87e2d31
ToppCellcontrol-Myeloid-mDC|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

KCTD12 CYP2S1 SLC4A3

6.83e-041934035e43024763932a679c33d83cf8f606612bc0f600
ToppCellMonocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis

PRKD3 KCTD12 SIGLEC8

6.83e-04193403198552810dcac8d0ca63a78badd6702b49ff6edf
ToppCell10x3'2.3-week_14-16-Myeloid_DC-DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KCTD12 SLC4A3 CYSLTR1

6.83e-04193403a32791b4bdb7c5f2b4cc75b660321ab75c4fac9b
ToppCellCOVID-19-Myeloid-DC2|Myeloid / Condition, Lineage and Cell class

CYP2S1 LDLRAD2 SLC4A3

6.83e-041934035f3f6db3d3de887d004662d229f42549601efa81
ToppCellfacs-Marrow-KLS-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MGAT4B GAA FTSJ3

6.93e-04194403c9ebdcc2ea600975dade68a41fa65d1f8a5a5926
ToppCellPBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

KCTD12 CYP2S1 SLC4A3

6.93e-04194403b16ed97eb6b7b7a220e943474c0d85c141b6e3a5
ToppCell10x5'v1-week_14-16-Myeloid_DC-DC-DC2|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KCTD12 CYP2S1 SLC4A3

6.93e-04194403a0cfc8c1cdc0722db39170e4417615b6e6b85041
ToppCellPBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

KCTD12 CYP2S1 SLC4A3

6.93e-041944032210f0755882d8f04edb4c109fb17c3f9149f6f7
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells)

ANKRD29 KCTD12 RTKN

6.93e-0419440388db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells)

ANKRD29 KCTD12 RTKN

6.93e-04194403a71728202493d4858342ea2756ea281cd0d99a3a
Diseaseautosomal dominant limb-girdle muscular dystrophy type 3 (implicated_via_orthology)

HNRNPDL HNRNPAB

2.41e-056382DOID:0110306 (implicated_via_orthology)
Diseasediet measurement

TSPEAR KCTD12 HPSE2 CACNA1H PRKDC NSF NUP210L

3.38e-041049387EFO_0008111
Diseasecandidiasis (implicated_via_orthology)

PRKD3 PRKD2

1.48e-0344382DOID:1508 (implicated_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
PFRFAGKRIFFLSSR

AGBL5

236

Q8NDL9
IAFFLRKFRNSRFLG

SLC4A3

906

P48751
RFLFGFGASTEFRTK

ANKRD29

96

Q8N6D5
RDFFFSRGRFSSGFR

DDIT4L

151

Q96D03
AKFALDGFFGSLRRE

HSD11B1L

181

Q7Z5J1
ADFEAGLLRGFRRRF

NT5C

16

Q8TCD5
GRSRGFGFVLFKDAA

HNRNPDL

186

O14979
RFGRDKVTFSFEAGR

DOK2

201

O60496
AAPGDRIRFQFRFFL

LDLRAD2

71

Q5SZI1
AKDSKGRFFIDRDGF

KCTD16

66

Q68DU8
GRFFIDRDGFLFRYI

KCTD16

71

Q68DU8
AAGDFIRFRFFQPLR

MGAT4B

431

Q9UQ53
GALRRKFGFSAEDYR

KCNK15

46

Q9H427
LFFGCRHKDRDYLFR

MTRR

576

Q9UBK8
FRLKDLDFASLARGF

DDX55

441

Q8NHQ9
RFLDADGRFRKHEAF

CYP2S1

416

Q96SQ9
FGFARIIGEKSFRRS

PRKD2

696

Q9BZL6
FGFARIIGEKSFRRS

PRKD3

721

O94806
GGLDKEFSDIFRRAF

NSF

221

P46459
AFLRFGGKRTDFLQF

HPSE2

111

Q8WWQ2
RLSRLKDFSFRFLFG

ACP2

231

P11117
FSKFFFSNRGRIRDV

NDUFAF1

256

Q9Y375
LFGEGFRAFVTDRDK

ATAD3C

56

Q5T2N8
RRDFTFNKDGFRDFP

GAA

411

P10253
LKLVAFGFRRFFKDR

CACNA1H

1666

O95180
SKGRFFLDRDGFLFR

KCTD12

76

Q96CX2
ASSRRRGFGLFFFLR

NUP210L

6

Q5VU65
LADFEGGFLRKFRAR

NT5M

46

Q9NPB1
EFKRGRFRLSLFSDL

RTKN

21

Q9BST9
TGRSRGFGFILFKDA

HNRNPAB

106

Q99729
DFLARGGSFITKVFR

FTSJ3

146

Q8IY81
KRDKGSYFFRLERGS

SIGLEC8

116

Q9NYZ4
DKRFRREFGDSKRVF

EIF4ENIF1

191

Q9NRA8
RFLLTASIFGFFGRA

CLDN34

91

H7C241
FFSGGNFRKRLSTFR

CYSLTR1

296

Q9Y271
VKDFTFEGFSRLRFL

ZER1

166

Q7Z7L7
REGFLYFRDRLGDTF

SLC27A5

541

Q9Y2P5
RFDAIRTFGFLSRLK

TMEM186

61

Q96B77
KDSGFFLRFIRARKF

RLBP1

91

P12271
GAFRRKFIQTFGKEF

PRKDC

3626

P78527
ARFFVGSRRRAKGLF

TSPEAR

196

Q8WU66